New Guidance on Resmetirom and Semaglutide for MASH

(MedPage Today) — At the American Association for the Study of Liver Diseases (AASLD) annual meeting, a session highlighted new guidance on using resmetirom (Rezdiffra) and semaglutide (Ozempic, Wegovy) for metabolic dysfunction-associated steatohepatitis…

Source link : https://www.medpagetoday.com/meetingcoverage/aasldvideopearls/118532

Author :

Publish date : 2025-11-14 18:51:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

New Guidance on Resmetirom and Semaglutide for MASH

The Trend of Unproven Peptides Is Spreading Through Influencers and RFK Jr. Allies

Rapid melt from Antarctica could help preserve crucial ocean current

Related Posts

Alcohol-Related Deaths Rise but Hospitalizations Hold Steady

Simple Strategy Can Slash ED Use in Older Cancer Patients

Oral Anticoagulants Raise Abnormal Uterine Bleeding Risk

Do Food Allergies Affect Growth Patterns in Children?

Ethosuximide Shows No Significant Benefit for IBS Pain

Safe spaces needed for drug-addicted children, say grieving mums

Alcohol-Related Deaths Rise but Hospitalizations Hold Steady

Simple Strategy Can Slash ED Use in Older Cancer Patients

Oral Anticoagulants Raise Abnormal Uterine Bleeding Risk

Do Food Allergies Affect Growth Patterns in Children?

Ethosuximide Shows No Significant Benefit for IBS Pain

Safe spaces needed for drug-addicted children, say grieving mums

The curious question of whether gut health affects ageing

How Often Do Physicians Encounter ‘Difficult’ Patients?

Categories

Archives